Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1989-6-15
pubmed:abstractText
Chromosome damage in vitro after bleomycin treatment during the late S and G2 phases of the cell cycle was studied in the peripheral lymphocytes of 19 untreated patients with primary testicular tumours and 22 age-matched healthy men with no excess of cancer incidence in the families. The occurrence of spontaneous chromosome aberrations was not shown to be different in the studied groups. However, in the lymphocytes treated with bleomycin, cancer patients exhibited higher numbers of break events per cell (1.06 versus 0.67, P less than 0.01) and increased frequency of cells with aberrations (55.0 versus 43.0, P less than 0.05) than control group. Aberrant cells of cancer patients had more aberrations than cells of the control sample (1.79 versus 1.53, P less than 0.01). The frequency of chromosome 1 aberrations, often encountered in cancer cells of testicular and other solid tumours, was significantly higher in lymphocytes of patients with testicular cancer (15.0 versus 8.4%, P less than 0.0001), the long arm of this chromosome being predominantly affected (12.0 versus 6.3%, P less than 0.0001). These results support the view that a genome disposed to testicular cancer is less effective in the ability to repair non-specific DNA damage in this region, more susceptible to damage, or both.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-2410094, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-2432831, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-2434215, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-2439200, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-2890020, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-3034800, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-3308827, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-3315187, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-3317175, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-3319010, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-3513945, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-3786672, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-6200055, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-6303985, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-6498819, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-6577447, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-6616439, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-6810003, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-70209, http://linkedlifedata.com/resource/pubmed/commentcorrection/2469452-7471097
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0007-0920
pubmed:author
pubmed:issnType
Print
pubmed:volume
59
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
499-502
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Increased breakage of chromosome 1 in lymphocytes of patients with testicular cancer after bleomycin treatment in vitro.
pubmed:affiliation
Paediatric Research Institute, Brno, Czechoslovakia.
pubmed:publicationType
Journal Article